Effects and mechanisms of acremoniumterricola milleretal mycelium on liver fibrosis induced by carbon tetrachloride in rats

American Journal of Chinese Medicine

Volumn 39, Issue 3, 2011, Pages 537-550

  Tian, Xiao Peng ^a   Yin, Yan Yan ^a   Li, Xia ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Acremoniumterricola milleretal mycelium (AMM); Antioxidant; Carbon Tetrachloride; Liver Fibrosis; Transforming Growth Factor 1

Indexed keywords

ACREMONIUMTERRICOLA MILLERETAL MYCELIUM; CARBON TETRACHLORIDE; CHINESE DRUG; HYALURONIC ACID; HYDROXYPROLINE; LAMININ; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SMAD7 PROTEIN; UNCLASSIFIED DRUG;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE HERB; CHINESE MEDICINE; CONTROLLED STUDY; LIPID PEROXIDATION; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

ACREMONIUM; ANIMALS; ANTIOXIDANTS; BIOLOGICAL AGENTS; CARBON TETRACHLORIDE; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GLUTATHIONE PEROXIDASE; HYALURONIC ACID; HYDROXYPROLINE; LAMININ; LIPID PEROXIDATION; LIVER; LIVER CIRRHOSIS; MALE; MYCELIUM; PHOSPHORYLATION; PROCOLLAGEN; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SMAD PROTEINS; SUPEROXIDE DISMUTASE; TRANSAMINASES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79957495692     PISSN: 0192415X     EISSN: 0192415X     Source Type: Journal    
DOI: 10.1142/S0192415X11009019     Document Type: Article

References (32)

1. Achliya, G.S., S.G. Wadodkar and A.K. Dorle. Evaluation of hepatoprotective effect of Amalkadi Ghrita against carbon tetrachloride induced hepatic damage in rats. J. Ethnopharmaco. 90: 229-232, 2004. (Pubitemid 38175413)
2. Bataller, R. and D.A. Brenner. Liver fibrosis. J. Clin. Invest. 115: 209-218, 2005. (Pubitemid 40385459)
3. 4-induced hepatic fibrogenesis in rats. World J. Gastroenterol. 13: 557-563, 2007. (Pubitemid 46210922)
4. Derynck, R. and Y.E. Zhang. Smad-dependent and Smad-independent pathways in TGF-family signalling. Nature 425: 577-584, 2003. (Pubitemid 37280136)
5. Drewa, G., E. Krzyzyska-Malinowska, A. Wozniak, F. Protas-Drozd, C. Mila-Kierzenkowska, M. Rozwodowska, B. Kowaliszyn and R. Czajkowski. Activity of superoxide dismutase and catalase and the level of lipid peroxidation products reactive with TBA in patients with psoriasis. Med. Set Monit. 8: 338-343, 2002.
6. Fowell, A.J. and J.P. Iredale. Emerging therapies for liver fibrosis. Dig. Dis. 24: 174-183, 2006.
7. Friedman, S.L. Stellate cells: a moving target in hepatic fibrogenesis. Hepatology. 40: 1041-1043, 2004. (Pubitemid 39425557)
8. Gebhardt, R. Oxidative stress, plant-derived antioxidants and liver fibrosis. PlantaMed. 68: 289-296, 2002. (Pubitemid 34494036)
9. Gressner, A.M., R. Weiskirchen, K. Breitkopf and S. Dooley. Roles of TGF-beta in hepatic fibrosis. Frontiers Biosci. 7: 793-807, 2002.
10. Gressner, A.M. and R. Weiskirchen. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J. Cellul. Molecul. Med. 10: 76-99, 2006. (Pubitemid 44874293)
11. Hernandez-Munoz, R., M. Diaz-Munoz, V. Lopez, F. Lopez-Barrera, L. Yanez, S. Vidrio, A. Aranda-Fraustro and V. Chagoya de Sanchez. Balance between oxidative damage and proliferative potential in an experimental rat model of CCI4-induced cirrhosis: protective role of adenosine administration. Hepatology 26: 1100-1110, 1997. (Pubitemid 27509289)
12. Hsu, C.L., C.C. Hsu and G.C. Yen. Hepatoprotection by freshwater clam extract against CC14-induced hepatic damage in rats. Am. J. Chin. Med. 38: 881-894, 2010.
13. Kaneda, H., E. Hashimoto, S. Yatsuji, K. Tokushige and K. Shiratori. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease. J. Gastroenterol. Hepatol. 21: 1459-1465, 2006. (Pubitemid 44154717)
14. Kopp, J. E. Preis and H. Said. Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts. J. Biol. Chem. 280: 21570-21576, 2005 (Pubitemid 40805724)
15. Li, C, J. Luo, L. Li, M. Cheng, N. Huang, J. Liu and M.P. Waalkes. The collagenolytic effects of the traditional Chinese medicine preparation, Han-Dan-Gan-Le, contribute to reversal of chemical-induced liver fibrosis in rats. Life Sci. 72: 1563-1571, 2003. (Pubitemid 36120784)
16. Li, C.H., L.H. Pan, Z.W. Yang, CY. Li and W.X. Xu. Preventive effect of Qianggan-Rongxian Decoction on rat liver fibrosis. World J. Gastroenterol. 14: 3569-3573, 2008.
17. Llessuy, SF. Introduccion y especies activas de oxigeno in estresse oxidativo e antioxidantes. Canoas: ULBRA. P: 21-31, 2002.
18. Lilian, De et al. Analysis on effective components in mycelia of AT01, a strain isolated from Acremonium terricola in submerged fermentation. Forest Pest Communic. 3: 7-9, 2000.
19. Mitchell, A.D. and I.E. Taylor. The spectrophotometric determination of hydroxyproline: an analytical investigation. Analyst. 95: 1003-1011, 1970.
20. Nakao A., M. Afrakhte and A. Moren. Identification of Smad7, a TGF-beta-inducible antagonist of TGF-beta signalling. Nature 389: 631-635, 1997 (Pubitemid 27446184)
21. Nikolaidis, N., J. Kountouras, O. Giouleme, V. Tzarou, O. Chatzizisi, K. Patsiaoura, A. Papageorgiou, M. Leontsini, N. Eugenidis and C. Zamboulis. Colchicine treatment of liver fibrosis. Hepato-gastroenterology 53: 281-285, 2006.
22. Nissen, N.N., P. Martin. Hepatocellular carcinoma: the high-risk patient. J. Clin. Gastroenterol. 35: S79-S85, 2002. (Pubitemid 35278645)
23. Okita, K., I. Sakaida and K. Hino. Current strategies for chemoprevention of hepatocellular carcinoma. Oncology 62: 24-28, 2002. (Pubitemid 34702016)
24. Polavarapu, R., D.R. Spitz, J.E. Sim, M.H. Follansbee, L.W. Oberley, A. Rahemtulla and A.A. Nanji. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 27: 1317-1323, 1998. (Pubitemid 28227859)
25. Poli, G. Pathogenesis of liver fibrosis: role of oxidative stress. Molecul. Aspect. Med. 21: 49-98, 2000. (Pubitemid 30642764)
26. Pinzani, M. and K. Rombouts. Liver fibrosis: from the bench to clinical targets. Dig. Liver Dis. 36: 231-242, 2004. (Pubitemid 41115470)
27. Shimizu, I., Y.R. Ma, Y. Mizobuchi, F. Liu, T. Miura, Y. Nakai, M. Yasuda, M. Shiba, T. Horie, S. Amagaya, N. Kawada, H. Hori and S. Ito. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29: 149-160, 1999. (Pubitemid 29023997)
28. Tsukada, S., C.J. Parsons and RA. Rippe. Mechanisms of liver fibrosis. Clinica Chimica Acta. 364: 33-60, 2006. (Pubitemid 43120627)
29. Wasser, S. and C.E. Tan. Experimental models of hepatic fibrosis in the rat. Ann. Academy Med. 28: 109-111, 1999.
30. Wu, S.J., K.W. Tarn, Y.H. Tsai, C.C. Chang and J.C. Chao. Curcumin and saikosaponin a inhibit chemical-induced liver inflammation and fibrosis in rats. Am. J. Chin. Med. 38: 99-111, 2010.
31. Yin, Yan-Yan, W.P. Li, H.L. Gong, F.F. Zhu, W.Z. Li and G.C. Wu. Protective effect of astragaloside on focal cerebral ischemia/reperfusion injury in rats. Am. J. Chin. Med. 38: 517-527, 2010.
32. Yu, H. O. Bock and A. Bayat. Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring. J. Plast. Reconstr. Aesthet. Surg. 59: 221-229, 2006.